We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GMED icon
51
Globus Medical
GMED
$11.2B
$926K 0.4%
+15,684
New +$1.01M
PNC icon
52
PNC Financial Services
PNC
$101B
$914K 0.4%
4,902
-3,309
-40% -$560K
TSN icon
53
Tyson Foods
TSN
$20.4B
$906K 0.39%
+16,187
New +$930K
BR icon
54
Broadridge
BR
$19B
$904K 0.39%
3,721
+2,205
+145% +$524K
PEN icon
55
Penumbra
PEN
$12.8B
$896K 0.39%
+3,493
New +$951K
RL icon
56
Ralph Lauren
RL
$23.6B
$881K 0.38%
3,211
-627
-16% -$155K
KEYS icon
57
Keysight
KEYS
$58.3B
$880K 0.38%
+5,373
New +$819K
C icon
58
Citigroup
C
$226B
$870K 0.38%
+10,215
New +$738K
SAM icon
59
Boston Beer
SAM
$1.92B
$868K 0.38%
4,548
+3,049
+203% +$702K
ADSK icon
60
Autodesk
ADSK
$52.6B
$863K 0.37%
+2,789
New +$791K
CCL icon
61
Carnival Corporation Ltd
CCL
$39.7B
$857K 0.37%
30,470
+14,978
+97% +$321K
BAC icon
62
Bank of America
BAC
$442B
$842K 0.37%
17,797
+5,068
+40% +$213K
UAL icon
63
United Airlines
UAL
$42.1B
$835K 0.36%
10,489
-503
-5% -$37.1K
TRGP icon
64
Targa Resources
TRGP
$55.1B
$831K 0.36%
4,772
-1,100
-19% -$185K
PG icon
65
Procter & Gamble
PG
$339B
$828K 0.36%
+5,194
New +$848K
DECK icon
66
Deckers Outdoor
DECK
$13.3B
$824K 0.36%
7,998
-1,958
-20% -$217K
ADI icon
67
Analog Devices
ADI
$190B
$823K 0.36%
+3,459
New +$720K
GWRE icon
68
Guidewire Software
GWRE
$14.2B
$821K 0.36%
+3,488
New +$749K
NTNX icon
69
Nutanix
NTNX
$16.9B
$816K 0.35%
10,669
+7,444
+231% +$536K
DD icon
70
DuPont de Nemours
DD
$19.2B
$809K 0.35%
9,398
+1,637
+21% +$136K
TMO icon
71
Thermo Fisher Scientific
TMO
$220B
$799K 0.35%
+1,971
New +$824K
ABNB icon
72
Airbnb
ABNB
$107B
$794K 0.34%
6,001
-3,236
-35% -$410K
ZG icon
73
Zillow
ZG
$7.63B
$791K 0.34%
+11,556
New +$765K
GFS icon
74
GlobalFoundries
GFS
$29.6B
$790K 0.34%
20,690
+7,338
+55% +$266K
FOX icon
75
Fox Class B
FOX
$23.9B
$789K 0.34%
+15,274
New +$744K
1 2
3
4 5

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.